The Goldman Sachs Group Lowers Stem (NYSE:STEM) Price Target to $2.00

Stem (NYSE:STEM) had its price target trimmed by The Goldman Sachs Group from $2.50 to $2.00 in a research note issued to investors on Monday, Benzinga reports. They currently have a neutral rating on the stock.

A number of other research firms have also weighed in on STEM. BMO Capital Markets lowered their target price on Stem from $2.50 to $1.85 and set a market perform rating for the company in a research note on Friday, May 3rd. Susquehanna dropped their price objective on Stem from $5.50 to $4.00 and set a positive rating for the company in a research note on Thursday, February 29th. Piper Sandler decreased their target price on shares of Stem from $3.00 to $2.00 and set a neutral rating on the stock in a research note on Thursday, April 11th. Evercore ISI dropped their price target on shares of Stem from $13.00 to $9.00 and set an outperform rating for the company in a research report on Friday, May 3rd. Finally, TD Cowen decreased their price objective on shares of Stem from $7.00 to $5.00 and set an outperform rating on the stock in a research report on Thursday, February 29th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of Hold and an average price target of $4.77.

Stem Trading Up 5.8 %

Shares of STEM stock opened at $1.37 on Monday. The business has a 50-day moving average price of $1.93 and a two-hundred day moving average price of $2.79. Stem has a 12-month low of $1.27 and a 12-month high of $7.79. The company has a quick ratio of 1.78, a current ratio of 1.88 and a debt-to-equity ratio of 1.23. The firm has a market cap of $215.36 million, a P/E ratio of -0.94 and a beta of 1.91.

Stem (NYSE:STEM) last issued its quarterly earnings results on Thursday, May 2nd. The company reported ($0.46) EPS for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.25). Stem had a negative net margin of 40.03% and a negative return on equity of 34.37%. The business had revenue of $25.50 million for the quarter, compared to the consensus estimate of $66.67 million. During the same quarter in the previous year, the business earned ($0.29) earnings per share. The firm’s revenue was down 61.9% on a year-over-year basis. Equities analysts anticipate that Stem will post -0.51 EPS for the current fiscal year.

Insider Activity

In related news, CRO Alan Russo sold 14,390 shares of the stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $3.17, for a total transaction of $45,616.30. Following the transaction, the executive now owns 158,204 shares in the company, valued at $501,506.68. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, CFO William John Bush sold 20,367 shares of the firm’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $3.17, for a total value of $64,563.39. Following the transaction, the chief financial officer now owns 276,814 shares of the company’s stock, valued at $877,500.38. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CRO Alan Russo sold 14,390 shares of Stem stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $3.17, for a total transaction of $45,616.30. Following the transaction, the executive now directly owns 158,204 shares in the company, valued at approximately $501,506.68. The disclosure for this sale can be found here. Over the last ninety days, insiders have acquired 130,418 shares of company stock valued at $238,045 and have sold 772,268 shares valued at $1,650,229. Corporate insiders own 10.17% of the company’s stock.

Institutional Trading of Stem

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Quadrature Capital Ltd increased its stake in Stem by 289.5% in the 3rd quarter. Quadrature Capital Ltd now owns 51,895 shares of the company’s stock worth $220,000 after buying an additional 38,570 shares in the last quarter. Lido Advisors LLC bought a new stake in shares of Stem during the third quarter valued at approximately $4,561,000. DNB Asset Management AS boosted its position in shares of Stem by 63.7% during the fourth quarter. DNB Asset Management AS now owns 126,568 shares of the company’s stock worth $491,000 after acquiring an additional 49,256 shares during the last quarter. Deutsche Bank AG lifted its stake in Stem by 3.8% in the 3rd quarter. Deutsche Bank AG now owns 605,722 shares of the company’s stock worth $2,568,000 after purchasing an additional 22,222 shares in the last quarter. Finally, SG Americas Securities LLC purchased a new position in shares of Stem during the fourth quarter valued at about $209,000. 61.63% of the stock is owned by hedge funds and other institutional investors.

About Stem

Stem, Inc operates as a digitally connected, intelligent, and renewable energy storage network provider worldwide. The company offers energy storage hardware sourced from original equipment manufacturers (OEMs); edge hardware to aid in the collection of site data and real-time operation and control of the site and other optional equipment; and Athena, a software platform, which offers battery hardware and software-enabled services to operate the energy storage systems.